Clinical Trials Directory

Trials / Completed

CompletedNCT04885582

The Relationship Between HLA Tissue Compatibility and Biliary Complications in Patients With Liver Transplantation

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Inonu University · Academic / Other
Sex
All
Age
1 Year – 70 Years
Healthy volunteers
Accepted

Summary

Liver transplantation has become the accepted treatment option for advanced liver failure in recent years. In addition to the increase in the number of centers performing transplant and the decrease in complication rates depending on the experience gained, the most common biliary complications did not improve at the desired level. For this reason, studies in this field are frequent today. The structural complexities of HLA antigens have been the subject of investigation in recent years. With the development of DNA and RNA amplification methods; It is increasingly difficult for physicians to keep up with the increasing burden of knowledge regarding the genetic aspects of these antigens. Concrete benefits of this gene complex, which has been investigated in various fields and preserves its mystery, have not been determined in liver transplant patients. However, there are publications showing its connection with the bile epithelium in liver transplantation and its relationship with the disappearing bile duct syndrome. In this study, our aim is to explain whether the bile duct complications, which appear like a continuous wall and can lead to frightening pictures, are related to HLA tissue compatibility.

Conditions

Interventions

TypeNameDescription
OTHERHLA antigen resultsHLA-A, HLA-B, HLA-DR tissue matching results in both groups will be compared.

Timeline

Start date
2017-05-10
Primary completion
2019-05-10
Completion
2020-05-20
First posted
2021-05-13
Last updated
2021-05-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04885582. Inclusion in this directory is not an endorsement.